Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Heliyon|December 11, 2023
Presence of MET exon 14 skipping and fusion as mechanism of osimertinb resistance in a lung adenocarcinoma with an EGFR exon 19 deletion that responds to combination of capmatinib and osimertinb: A case reportSiqi Xiang, Liang Zeng, Mingjun Xiang, et al.Journal of Cancer Research and Clinical Oncology|March 7, 2014
Nrf2: bane or blessing in cancer?MingJun Xiang, Akhileshwar Namani, ShiJun Wu, et al.Optics Express|June 14, 2025
Reconstruction of partially obscured objects with a physics-driven self-training neural networkMingjun Xiang, Kai Zhou, Hui Yuan, et al.International Journal of Molecular Sciences|December 11, 2012
Inhibitor of apoptosis protein-like protein-2 as a novel serological biomarker for breast cancerMingjun Xiang, Wei Zhou, Dandan Gao, et al.Applied Optics|March 17, 2026
Status of three-dimensional terahertz Fourier imaging for industrial application [Invited]Hui Yuan, Aparajita Bandyopadhyay, Nan Zhang, et al.Molecular Medicine Reports|January 18, 2022
Proteomic analysis of inhibitor of apoptosis protein‑like protein‑2 on breast cancer cell proliferationSiqi Xiang, Lin Zhu, Zhiliang Zhang, et al.Frontiers in Oncology|July 11, 2022
ILP-2: A New Bane and Therapeutic Target for Human CancersZhiliang Zhang, Siqi Xiang, Ruxia Cui, et al.Scandinavian Journal of Gastroenterology|March 1, 2021
Magnesium deficiency in liver cirrhosis: a retrospective studyXia Peng, Rengyun Xiang, Xuefeng Li, et al.Neuro-Signals|October 5, 2017
Stimulation of Anxiety-Like Behavior via ERK Pathway by Competitive Serotonin Receptors 2A and 1A in Post-Traumatic Stress Disordered MiceMingjun Xiang, Yuting Jiang, Zhiying Hu, et al.Sheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology|October 8, 2008
[hARD1 antiserum preparation and primary immunohistochemical analysis of hARD1 in tumor tissues]Min Yu, Chao Huang, Mingjun Xiang, et al.Pageof 2